ConductScience.org, home

Paper9749478

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

D'Amico AV and 10 others. JAMA, 1998. Cited by 3,731 papers, by iCite.

Cite this record

ConductScience Library. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. Papers, record 9749478. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9749478

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.
PubMed
Journal
JAMA
PubMed
Year
1998
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
3,731
iCite
Relative citation ratio, by iCite
98.5
iCite
Revised in PubMed
2022-04-09
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1D'Amico AVA V
2Whittington RR
3Malkowicz SBS B
4Schultz DD
5Blank KK
6Broderick GAG A
7Tomaszewski JEJ E
8Renshaw AAA A
9Kaplan II
10Beard CJC J
11Wein AA

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Prostate-Specific AntigenMajor topic
Prostatic NeoplasmsMajor topic
Antineoplastic Agents, Hormonal
Brachytherapy
Chemotherapy, Adjuvant
Follow-Up Studies
Humans
Male
Multivariate Analysis
Neoplasm Staging
Proportional Hazards Models
Prostatectomy
Radiotherapy Dosage
Retrospective Studies
Survival Analysis

Source PubMed

Download CSV of topics

Trials12

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00693238Proton Therapy for Low and Intermediate Risk Prostate CancerBackgroundClinicalTrials.gov
NCT01040624Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate CancerBackgroundClinicalTrials.gov
NCT01368055Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate CancerBackgroundClinicalTrials.gov
NCT01655836High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate CancerBackgroundClinicalTrials.gov
NCT01848067Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate CancerBackgroundClinicalTrials.gov
NCT02156414Lymph Node Involvement Using Extended Pelvic Lymphadenectomy in Clinically Localized Prostate CancerBackgroundClinicalTrials.gov
NCT03255135Initial Experience in Brazilian Single Center With High Intensity Focalized Ultrasound (HIFU) Prostate Cancer Therapy: Morbidity, Oncological and Functional Outcomes.BackgroundClinicalTrials.gov
NCT03289221Effects of High-Intensity Focused Ultrasound (HIFU) Treatment on Fecal Continence and Anorretal FisiologyResultsClinicalTrials.gov
NCT03829930Combination of Entinostat and Enzalutamide in Advanced Prostate CancerBackgroundClinicalTrials.gov
NCT03864939Application of Dried Human Amnion Graft to Improve Postprostatectomy Incontinence and PotencyBackgroundClinicalTrials.gov
NCT04261777Ferumoxtran-10-enhanced MRI in Prostate Cancer PatientsBackgroundClinicalTrials.gov
NCT06798558Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical ProstatectomyBackgroundClinicalTrials.gov

Download CSV of trials

Comments and corrections5

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in9749485Comparing treatments for localized prostate cancer--persisting uncertainty.https://conductscience.org/library/papers/9749485PubMed
Comment in10235143Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.https://conductscience.org/library/papers/10235143PubMed
Comment in10235144Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.https://conductscience.org/library/papers/10235144PubMed
Comment in10235145Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.https://conductscience.org/library/papers/10235145PubMed
Comment in10235146Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.https://conductscience.org/library/papers/10235146PubMed

Download CSV of comments and corrections

Cited by1,682

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3,731 citations.

PMIDTitleJournalYearIn PapersSource
42982989Long-term fatigue based on the EORTC QLQ-C30 up to five years after radiotherapy and its trajectories in men diagnosed with non-metastatic prostate cancer in the international REQUITE study.Br J Cancer2026https://conductscience.org/library/papers/42982989PubMed
42955349Implementation of the HUGO™ RAS system for robot-assisted radical prostatectomy: a single-center comparison with the da Vinci Xi® system.World J Urol2026https://conductscience.org/library/papers/42955349PubMed
42922617Tumor-adjacent B cell infiltration stratifies recurrence risk in localized prostate cancer.medRxiv2026https://conductscience.org/library/papers/42922617PubMed
42903118Prognostic value of postoperative dynamic PNI trajectories for biochemical recurrence in patients with high-risk localized prostate cancer: a longitudinal trajectory clustering study.Front Nutr2026https://conductscience.org/library/papers/42903118PubMed
42871139Personalized Boolean network dynamic profiling and machine learning approaches to identify combinatorial treatments for prostate cancer.Front Pharmacol2026https://conductscience.org/library/papers/42871139PubMed
42866815Comparative outcomes of radical prostatectomy, radiotherapy, and radiotherapy plus androgen deprivation therapy for high-risk and very high-risk prostate cancer: a narrative review.Transl Androl Urol2026https://conductscience.org/library/papers/42866815PubMed
42861175Artificial intelligence-based prostate cancer risk stratification via large-scale ultrasound images paired with histopathology.Quant Imaging Med Surg2026https://conductscience.org/library/papers/42861175PubMed
42829772Incidence, Patterns, and Predictive Factors of Biochemical Failure Following Definitive Radiotherapy for Localized Prostate Cancer: A Retrospective Military Cohort Study.Cureus2026https://conductscience.org/library/papers/42829772PubMed
42821058Baseline Ga-68 PSMA PET/CT-derived volumetric parameters as predictors of biochemical recurrence following radical prostatectomy.Ann Nucl Med2026https://conductscience.org/library/papers/42821058PubMed
42802268Stage migration in prostate cancer: the role of PSMA-PET in identifying oligometastatic disease.Eur J Nucl Med Mol Imaging2026https://conductscience.org/library/papers/42802268PubMed
42781078Validation of Comprehensive Prostate Cancer Assessment on Sexual Health for Men Who Have Sex With Men (COMPASS).JU Open Plus2026https://conductscience.org/library/papers/42781078PubMed
42736457Development and validation of a preoperative 18F-PSMA-1007 PET/MR prognostic model for predicting biochemical recurrence in prostate cancer: a multicentre study.Eur J Nucl Med Mol Imaging2026https://conductscience.org/library/papers/42736457PubMed
42731831PROspective Prostate Cancer Infrastructure: study protocol for the ProPCI 'trials within cohorts' study.BMJ Open2026https://conductscience.org/library/papers/42731831PubMed
42694552Potential impact of NUCB2 genetic variants with the clinicopathological characteristics of prostate cancer.Int J Med Sci2026https://conductscience.org/library/papers/42694552PubMed
42660995Deep learning augmented pathological grading and intraductal carcinoma of the prostate signatures improve recurrence prediction after intensity-modulated radiation therapy.Virchows Arch2026https://conductscience.org/library/papers/42660995PubMed
42652119ISUP Grade Group Migration Between Prostate Biopsy and Radical Prostatectomy: A Systematic Review of Emerging Predictors.Biomedicines2026https://conductscience.org/library/papers/42652119PubMed
42642558Explainable artificial intelligence reveals key surgical parameters in robot-assisted and open radical prostatectomy.Sci Rep2026https://conductscience.org/library/papers/42642558PubMed
42638189Discordant molecular biomarkers in unfavorable intermediate-risk localized prostate cancer.CA Cancer J Clin2026https://conductscience.org/library/papers/42638189PubMed
42536276Impact of lymph node yield on biochemical recurrence in patients with high-risk prostate cancer after robot-assisted radical prostatectomy.Int J Clin Oncol2026https://conductscience.org/library/papers/42536276PubMed
42533777[18F]PSMA-1007 PET-Based Recurrence Site Distribution and Predictors of Metastatic Disease in Patients With Biochemical Recurrence of Prostate Cancer.Int J Urol2026https://conductscience.org/library/papers/42533777PubMed

See all 1,682 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
KLK3354PubTator's text mininghttps://conductscience.org/library/genes/354

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9749478

GET https://conductscience.org/api/papers/v1/9749478/cited_by?page=2